Mark Doherty | Senior Manager, Global Medical Affairs
GSK

WVIC/WAC Day 1 - Nov 29 @ 10:00

Defining immune health and its implications for ID & Cancer

• How do we define immune fitness / immune health – progress towards human immunome
• How are we studying this at a systems level? How do vaccines positively impact immune fitness?
• Defining tumor archetypes – what common immunological features contribute to better response rates

Moderator: Ananda Goldrath, Tata Chancellor's Endowed Professor in Molecular Biology, UCSD

×

Ananda Goldrath / Defining immune health and its implications for ID & Cancer

Ananda Goldrath, Tata Chancellor's Endowed Professor in Molecular Biology,
UCSD

Ananda Goldrath is a Tata Chancellor’s Professor in the Division of Biological Sciences and former chair of the Molecular Biology Section at the University of California, San Diego, where she started her lab in 2004.

Close

Bali Pulendran, Professor, Department Of Pathology, Microbiology And Immunology, Stanford University School of Medicine (USA)

×

Bali Pulendran / Defining immune health and its implications for ID & Cancer

Bali Pulendran, Professor, Department Of Pathology, Microbiology And Immunology,
Stanford University School of Medicine (USA)

Professor Bali Pulendran is the Violetta L. Horton Professor at the Stanford University School of Medicine, and a member of the Institute for Immunology, Transplantation and Infection, and the Departments of Pathology and Microbiology & Immunology at Stanford University. He is also an adjunct...

CloseMore

Mark Doherty, Senior Manager, Global Medical Affairs, GSK

×

Mark Doherty / Defining immune health and its implications for ID & Cancer

Mark Doherty, Senior Manager, Global Medical Affairs,
GSK

Current work involves training (both for internal staff and for external medical professionals) and speaking to external audiences on vaccine development and immunology. Also involved in drafting policy documents in the area of vaccine development, public health and immunodiagnosis.

Close

Rafick-Pierre Sékaly, Professor and Vice-Chair of Translational Medicine, Emory University - School of Medicine

×

Rafick-Pierre Sékaly / Defining immune health and its implications for ID & Cancer

Rafick-Pierre Sékaly, Professor and Vice-Chair of Translational Medicine,
Emory University - School of Medicine

Rafick-Pierre Sékaly, PhD, is Professor and serves as Vice-Chair of Translational Medicine in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine in Atlanta, Georgia. Dr. Sékaly is a Georgia Research Alliance Eminent Scholar. He is a member of the Cancer...

CloseMore